Status:
WITHDRAWN
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Hospital for Special Surgery, New York
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-65 years
Brief Summary
It is well known that the deregulation of immune responses plays a major role in many autoimmune diseases, such as Systemic Lupus Erythematosus (SLE). The main objective of this protocol is to determi...
Detailed Description
This will be a case control study, where cases of SLE will be compared to controls of healthy volunteers to assess risk factors. As these healthy volunteers are providing samples solely for research p...
Eligibility Criteria
Inclusion
- Must provide informed consent
- Males and females, age 18 years and older
- Healthy Nonsmokers
Exclusion
- If the subject has
- Rheumatic disease
- Diabetes
- SLE or lupus
- Autoimmune disease
- Active infection or pregnancy
- HIV infection
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02270710
Start Date
April 1 2013
End Date
October 1 2016
Last Update
May 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Medical College of Cornell University
New York, New York, United States, 10021